ABL Bio Inc. (KOSDAQ:298380)
205,000
-10,500 (-4.87%)
Jan 9, 2026, 12:00 PM KST
547.71% (1Y)
| Market Cap | 11.88T |
| Revenue (ttm) | 88.44B |
| Net Income (ttm) | -28.65B |
| Shares Out | 55.13M |
| EPS (ttm) | -575.68 |
| PE Ratio | n/a |
| Forward PE | 1,073.45 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 494,521 |
| Average Volume | 998,954 |
| Open | 212,500 |
| Previous Close | 215,500 |
| Day's Range | 203,500 - 213,500 |
| 52-Week Range | 29,400 - 224,000 |
| Beta | 0.51 |
| RSI | 65.42 |
| Earnings Date | Feb 6, 2026 |